Peter G. Schultz
|1985-1999||University of California, Berkeley, Berkeley, CA|
|1999-||Scripps Research Institute|
Google:"Peter G. Schultz"
The 1994/5 Wolf Prize in Chemistry: Richard A. Lerner and Peter G. Schultz for converting antibodies into enzymes, thus permitting the catalysis of chemical reactions considered impossible to achieve by classical chemical procedures.
Mean distance: 6.48
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Li JC, Liu T, Wang Y, et al. (2018) Enhancing Protein Stability with Genetically Encoded Noncanonical Amino Acids. Journal of the American Chemical Society|
|Ahmed N, De Graaf JF, Ahmed N, et al. (2018) Visualization of the Delivery and Release of Small RNAs Using Genetic Code Expansion and Unnatural RNA-Binding Proteins. Bioconjugate Chemistry|
|Mehta AP, Supekova L, Chen JH, et al. (2018) Engineering yeast endosymbionts as a step toward the evolution of mitochondria. Proceedings of the National Academy of Sciences of the United States of America|
|Bollong MJ, Lee G, Coukos JS, et al. (2018) A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature|
|Janes J, Young ME, Chen E, et al. (2018) The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Proceedings of the National Academy of Sciences of the United States of America|
|Mehta AP, Wang Y, Reed SA, et al. (2018) Bacterial Genome Containing Chimeric DNA-RNA Sequences. Journal of the American Chemical Society|
|Abdeen S, Kunkle T, Salim N, et al. (2018) Sulfonamido-2-arylbenzoxazole GroEL/ES inhibitors are potent antibacterials against methicillin-resistant Staphylococcus aureus (MRSA). Journal of Medicinal Chemistry|
|Miglianico M, Eldering M, Slater H, et al. (2018) Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases. Proceedings of the National Academy of Sciences of the United States of America|
|Zhong L, Tran T, Baguley TD, et al. (2018) A Novel Inhibitor of iNOS Dimerization Protects Against Cytokine-Induced Rat β-cell Dysfunction. British Journal of Pharmacology|
|Zhang G, Baidin V, Pahil KS, et al. (2018) Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors. Proceedings of the National Academy of Sciences of the United States of America|